ICUI

ICU Medical Announces First Quarter 2024 Results

Retrieved on: 
Tuesday, May 7, 2024

SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024.

Key Points: 
  • SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024.
  • First quarter 2024 revenue was $566.7 million, compared to $568.6 million in the same period in the prior year.
  • Adjusted diluted earnings per share for the first quarter of 2024 was $0.96 as compared to $1.74 for the first quarter of 2023.
  • Adjusted EBITDA was $78.8 million for the first quarter of 2024 as compared to $102.0 million for the first quarter of 2023.

ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call

Retrieved on: 
Tuesday, April 23, 2024

SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call.

Key Points: 
  • SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call.
  • The Company will release its first quarter 2024 results on Tuesday, May 7th, 2024 at approximately 4:00 p.m.
  • ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m.
  • ET (1:30 p.m. PT) on Tuesday, May 7th, 2024.

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum

Retrieved on: 
Wednesday, March 13, 2024

SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024.

Key Points: 
  • SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024.
  • ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m.
  • Company management will also be participating in one-on-one meetings on Wednesday, March 20, 2024.
  • The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com , clicking on the Investors tab and clicking on the Event Calendar tab.

ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference

Retrieved on: 
Friday, March 1, 2024

SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024.

Key Points: 
  • SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024.
  • ICU Medical’s presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m.
  • Company management will also be participating in one-on-one meetings on Monday, March 4, 2024.
  • The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com , clicking on the Investors tab and clicking on the Event Calendar tab.

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance

Retrieved on: 
Tuesday, February 27, 2024

Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year.

Key Points: 
  • Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year.
  • GAAP gross profit for the fourth quarter of 2023 was $171.6 million, as compared to $174.9 million in the same period in the prior year.
  • Adjusted diluted earnings per share for the fourth quarter of 2023 was $1.57 as compared to $1.60 for the fourth quarter of 2022.
  • Also, adjusted EBITDA was $86.3 million for the fourth quarter of 2023 as compared to $96.4 million for the fourth quarter of 2022.

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call

Retrieved on: 
Tuesday, February 13, 2024

SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call.

Key Points: 
  • SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call.
  • The Company will release its fourth quarter 2023 results on Tuesday, February 27th, 2024 at approximately 4:00 p.m.
  • ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m.
  • The call can be accessed at (833) 816-1376, conference ID 10186026.

ICU Medical Announces Third Quarter 2023 Results

Retrieved on: 
Monday, November 6, 2023

SAN CLEMENTE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2023.

Key Points: 
  • SAN CLEMENTE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2023.
  • Third quarter 2023 revenue was $553.3 million, compared to $597.9 million in the same period last year.
  • Also, adjusted EBITDA was $89.8 million for the third quarter of 2023 as compared to $92.6 million for the third quarter of 2022.
  • Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Third quarter results were generally in line with our previously revised expectations."

ICU Medical Announces Time of Third Quarter 2023 Earnings Conference Call

Retrieved on: 
Monday, October 23, 2023

SAN CLEMENTE, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call.

Key Points: 
  • SAN CLEMENTE, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call.
  • The Company will release its third quarter 2023 results on Monday, November 6th, 2023 at approximately 4:00 p.m.
  • ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m.
  • ET (1:30 p.m. PT) on Monday, November 6th, 2023.

ICU Medical to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference

Retrieved on: 
Tuesday, September 5, 2023

SAN CLEMENTE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Morgan Stanley Annual Global Healthcare Conference at 4:30 a.m. PT (7:30 a.m.

Key Points: 
  • SAN CLEMENTE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Morgan Stanley Annual Global Healthcare Conference at 4:30 a.m. PT (7:30 a.m.
  • ET) on Tuesday, September 12, 2023.
  • Company management will also be participating in one-on-one meetings on Tuesday, September 12, 2023.
  • The fireside chat will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com , clicking on the Investors tab and clicking on the Event Calendar tab.

PolyU hosts the Global Smart Cities Summit cum the 3rd International Conference on Urban Informatics attracting over 500 global scholars and industry professionals

Retrieved on: 
Monday, August 21, 2023

HONG KONG, Aug. 21, 2023 /PRNewswire/ -- The Global Smart Cities Summit cum the 3rd International Conference on Urban Informatics (GSCS & ICUI 2023), organised by the International Society for Urban Informatics (ISUI) and the PolyU Otto Poon Charitable Foundation Smart Cities Research Institute (SCRI), commenced today.

Key Points: 
  • HONG KONG, Aug. 21, 2023 /PRNewswire/ -- The Global Smart Cities Summit cum the 3rd International Conference on Urban Informatics (GSCS & ICUI 2023), organised by the International Society for Urban Informatics (ISUI) and the PolyU Otto Poon Charitable Foundation Smart Cities Research Institute (SCRI), commenced today.
  • This three-day conference has attracted over 500 participants globally and over 230 speakers will share their insights and research on urban informatics and smart cities.
  • It provides an excellent platform for exchanging information about state-of-the-art technologies and innovations in smart cities and urban informatics.
  • The Outstanding Achievement Award in Urban Informatics honours world-renowned scholars in recognition of their significant contributions to the field of Urban Informatics.